MAX
Apellis Pharmaceuticals, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
-14.97 | 29.98 | -149.92% | -11.17 | +34.03% |
| P/S |
|
5.06 | 127.74 | -96.04% |
|
|
| P/BV |
|
17.29 | 249.13 | -93.06% |
|
|
| P/FCF |
|
-33.55 | -171.72 | -80.46% |
|
|
| Ev/Ebitda |
|
-25.96 | -23.82 | 8.96% |
|
|
| Ev/S |
|
5.13 | 524.37 | -99.02% |
|
|
| Ev/FCF |
|
-45.44 | -276.27 | -83.55% |
|
|
| E/P |
|
-0.0668 | 0.0223 | -399.29% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-19.78 | -358.56 | -94.48% | -200.56 | -90.14% |
| ROE |
|
-93.55 | 102.4 | -191.35% |
|
|
| ROA |
|
-23.64 | -1.94 | 1117.46% |
|
|
| ROIC |
|
-121.89 | 0.7 | -17394.38% |
|
|
| ROS |
|
-21.11 | -148.28 | -85.76% |
|
|
| ROCE |
|
-68.4 | 3.78 | -1911.4% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-3.04 | 1.52 | -300.24% | -1.91 | +59.55% |
| Nеt Debt/Ebitda |
|
-0.38 | 1.46 | -125.92% |
|
|
| Debt/Ratio |
|
0.53 | 0.2 | 168.39% |
|
|
| Debt/Equity |
|
2.87 | 1.61 | 78.75% |
|
|
| Debt/Net Income |
|
-2.37 | -1.12 | 111.32% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.55 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.91 | -100% | ||
| DSI |
|
0 | 0.22 | -100% |
|
|
| Average dividend growth |
|
0 | 3.92 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.51 | -100% |
|
|
| Average percentage for payments |
|
0 | 56.13 | -100% |
|
|
| Difference from average difference in sector |
|
-0.55 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
211.8 | -47.77 | -543.37% | ||
| Growth impulse Ebitda in 5 years |
|
-26.2 | -76.11 | -65.58% | ||
| Growth impulse Net Income in 5 years |
|
-42.63 | -71.25 | -40.17% | ||
| Growth impulse FCF in 5 years |
|
-46.79 | -63.52 | -26.34% | ||
| Growth impulse EPS in 5 years |
|
-65.21 | -37.1 | 75.77% |
IP Score
2.69/10
